576 related articles for article (PubMed ID: 29060925)
1. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.
Oakley-Girvan I; Davis SW
Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925
[TBL] [Abstract][Full Text] [Related]
2. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
3. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up.
Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G
Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677
[TBL] [Abstract][Full Text] [Related]
4. Detection of volatile organic compounds in exhaled breath to screen lung cancer: a systematic review.
Hua Q; Zhu Y; Liu H
Future Oncol; 2018 Jul; 14(16):1647-1662. PubMed ID: 29939068
[TBL] [Abstract][Full Text] [Related]
5. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF
J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489
[TBL] [Abstract][Full Text] [Related]
6. Real-time ultrasensitive VUV-PIMS detection of representative endogenous volatile markers in cancers.
Li Z; Shu J; Zhang P; Sun W; Yang B; Zhang H
Cancer Biomark; 2016; 16(3):477-87. PubMed ID: 27062705
[TBL] [Abstract][Full Text] [Related]
7. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
[TBL] [Abstract][Full Text] [Related]
8. Volatile signature for the early diagnosis of lung cancer.
Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L
J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451
[TBL] [Abstract][Full Text] [Related]
9. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
[TBL] [Abstract][Full Text] [Related]
10. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis by Volatile Organic Compounds in Exhaled Breath from Lung Cancer Patients Using Support Vector Machine Algorithm.
Sakumura Y; Koyama Y; Tokutake H; Hida T; Sato K; Itoh T; Akamatsu T; Shin W
Sensors (Basel); 2017 Feb; 17(2):. PubMed ID: 28165388
[TBL] [Abstract][Full Text] [Related]
12. Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath.
Chen X; Wang F; Lin L; Dong H; Huang F; Ghulam Muhammad K; Chen L; Gorlova OY
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29068415
[TBL] [Abstract][Full Text] [Related]
13. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors.
Peng G; Hakim M; Broza YY; Billan S; Abdah-Bortnyak R; Kuten A; Tisch U; Haick H
Br J Cancer; 2010 Aug; 103(4):542-51. PubMed ID: 20648015
[TBL] [Abstract][Full Text] [Related]
14. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
[TBL] [Abstract][Full Text] [Related]
15. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis.
Zhou J; Huang ZA; Kumar U; Chen DDY
Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702
[TBL] [Abstract][Full Text] [Related]
16. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
17. Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
Phillips M; Bauer TL; Cataneo RN; Lebauer C; Mundada M; Pass HI; Ramakrishna N; Rom WN; Vallières E
PLoS One; 2015; 10(12):e0142484. PubMed ID: 26698306
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive detection of colorectal cancer by analysis of exhaled breath.
Wang C; Ke C; Wang X; Chi C; Guo L; Luo S; Guo Z; Xu G; Zhang F; Li E
Anal Bioanal Chem; 2014 Jul; 406(19):4757-63. PubMed ID: 24820062
[TBL] [Abstract][Full Text] [Related]
19. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.
Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W
Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760
[TBL] [Abstract][Full Text] [Related]
20. Calculated indices of volatile organic compounds (VOCs) in exhalation for lung cancer screening and early detection.
Chen X; Muhammad KG; Madeeha C; Fu W; Xu L; Hu Y; Liu J; Ying K; Chen L; Yurievna GO
Lung Cancer; 2021 Apr; 154():197-205. PubMed ID: 33653598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
